The comparison between virtual screening and physical screening has become a central topic in modern drug discovery, as laboratories seek to balance efficiency and certainty. Advances in computational ...

On May 20, 2026, Viva Biotech hosted a V-Experts in Conversation webinar, "Managing Complexity in Modern Drug Discovery: A Practical Approach to Integrated Screening & Chemistry." Moderated by ...

The speakers discussed how an integrated screening and medicinal chemistry workflow can support decision-making from hit identification through lead optimization. Dr. Xia emphasized that hit ...

Australian researchers, led by Monash University, have invented a new artificial intelligence (AI) tool which is poised to reshape virtual screening in early stage drug discovery and enhance ...

Machine learning is changing the front end of drug discovery, where researchers decide which targets to pursue and which molecules deserve costly laboratory work. Its deeper test lies further ...

Researchers from Tsinghua University and Peking University have unveiled DrugCLIP, a new AI-driven screening program they say could speed up drug discovery (Science 2026, DOI: 10.1126/science.ads9530) ...

In drug discovery, virtual screening is a fast and cost-effective way of narrowing down vast chemical libraries to identify the most promising hits, reducing synthesis and testing requirements while ...

Flying on a plane out of Boston, Paul Belcher broke the habit of a lifetime. I’m an introvert; I do not like people talking to me on aeroplanes,” he says. But the man sitting next to him started ...

Improved content discoverability via Reaxys® Medicinal Chemistry combined with data integration capabilities allow chemists to identify and optimize promising lead candidates Elsevier, a world-leading ...